Welch Allyn RETeval-DR Electroretinograph

$8,189.95
RRP $12,284.93
SAVE $4,094.98 (33%)
In Stock
Prices Include GST. Ships from Australia with Express Courier


Calculate Shipping

Welch Allyn RETeval-DR Electroretinograph

The Welch Allyn RETeval-DR Electroretinograph is designed for improve the management of patients with diabetes. In three minutes, you can objectively screen for vision-threatening diabetic retinopathy (VTDR) wherever patients receive care. Welch Allyn RETeval-DR Electroretinograph enables efficient, comfortable, non-mydriatic screening for VTDR that improves patient compliance to help preserve vision in your patients with diabetes.

Features:
  • High accuracy and low technical failure rate
  • Handheld and battery powered
  • Immediate test results and report
  • No installation and minimal training required
  • Allows for screening of Mild Non-Proliferative DR, Moderate Non-Proliferative DR
  • ​Proliferative DR, Proliferative DR, Clinically Significant Macular Edema
  • Non-mydriatic screening process
  • Built in pupilometer which enables adjustment on the flash intensity
  • Fast 3 minutes screening with results immediately available
  • Warranty: 1 year 

(MWARETEVAL-001)

SKU MWARETEVAL-001
Brand Welch Allyn

Be The First To Review This Product!

Help other Meddoc Pty Ltd users shop smarter by writing reviews for products you have purchased.

Write a product review


More From This Category